Quality indicators for appropriate medication use in vulnerable elders

Ann Intern Med. 2001 Oct 16;135(8 Pt 2):703-10. doi: 10.7326/0003-4819-135-8_part_2-200110161-00009.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Analgesics, Opioid
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Barbiturates
  • Chlorpropamide
  • Cholinergic Antagonists
  • Contraindications
  • Diuretics / adverse effects
  • Diuretics / therapeutic use
  • Drug Prescriptions*
  • Drug Therapy / statistics & numerical data
  • Drug-Related Side Effects and Adverse Reactions*
  • Evidence-Based Medicine
  • Frail Elderly*
  • Health Services for the Aged / standards*
  • Humans
  • Hypoglycemic Agents
  • Kidney Function Tests
  • Meperidine
  • Monitoring, Physiologic
  • Patient Education as Topic
  • Quality Indicators, Health Care*
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Analgesics, Opioid
  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Barbiturates
  • Cholinergic Antagonists
  • Diuretics
  • Hypoglycemic Agents
  • Warfarin
  • Meperidine
  • Chlorpropamide